PAI-1 reduction after treatment with glutathione in NIDDM

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 63-65

  Martina, V ^a,b   Bruno, G A ^a   Pannocchia, A ^a   Zumpano, E ^a   Tagliabue, M ^a   Trucco, F ^a   Giorgianni, A ^a   Stella, S ^a   Pescarmona, G P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; GLUTATHIONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029855994     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80052-X     Document Type: Conference Paper

References (15)

1. Bachmann F. Fibrinolysis. In: Verstraete M, Vermylen J Lijnen H R, Arnout J, ed. Thrombosis and Haemostasis. Leuven: Leuven University Press, 1987: 227-265.
2. Prince M H, Hirsch J. A critical review of the relationship between impaired fibrinolysis and miocardial infarction. Amer Heart J 1991; 122: 545-551.
3. Auwerx J, Bouillon R, Collen D, Geboers D. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988; 8: 68-72.
4. Garcia Frade L J, De La Galle H, Torrado M C, Lara J I, Cuellar L, Garcia A. Hypofibinolysis associated with vasculopathy in non-insulin-dependent diabetes mellitus. Thromb Res 1990; 59: 51-59.
5. Skrha J, Hodinar A, Kvasnicka J, Hilgertova J. Oxidative stress and fibrinolysis in diabetes mellitus. Diabetologia 1995; 38 (Suppl 2): A252.
6. Maiello M, Boeri D, Podesta F. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in glucose. Diabetes 1992; 41: 1009-1015.
7. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992; 32: H321-H326.
8. Ceriello A, Curcio F, Dello Russo P, Pegoraro I, Stel G, Amstad P, Cerutti P. The defence against free radicals protects endothelial cells from hyperglycemia-induced plasminogen activator inhibitor 1 over production. Blood Coagulation and Fibrinolysis 1995; 6: 133-137.
9. Baynes JW. Role of oxidative stress in development of complication in diabetes. Diabetes 1991; 40: 405-412.
10. Beutler E. Red cell metabolism. In: Grune & Stratton ed. A manual of biochemical methods. New York and London, 1973, 103-105.
11. DeClerk PJ, Alessi MC, Vertreken M, Kruithoff EKO, Vague I, Collen D. Measurement of plasminogen activator inhibitor - 1 in biological fluids with a murine monoclonal antibody-based enzyme linked immunosorbent assay. Blood 1988; 71: 220-225.
12. Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple sensitive spectrophotometric assay for extrinsic (tissue -type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1989; 48:266-269.
13. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red cells. J Biol Chem 1989; 264: 21340-21345.
14. Pescarmona GP, Bosia A, Ghigo D. Shortened red cell life span in diabetes: mechanism of hemolysis. In: Weatherall DJ, Fiorelli G, Gorinio S (eds): Advances in Red Cell Biology. New York, NY, Raven, 1982, 391-397.
15. Simonelli F, Nasti A, Pensa M, Romano L, Savastano S, Rinaldi E, Auricchio G. Lipid peroxidation and human caractogenesis in diabetes and severe myopia. Exp Eye Res 1989; 49: 181-187.